Skip to main content

Staff Profile

Dr Christopher Duncan

MRC Clinician Scientist Fellow, Honorary Consultant in Infectious Diseases

  • Telephone: +44 (0)191 2082796
  • Address: Translational and Clinical Research Institute
    Immunity & Inflammation Theme
    Room M3.136C Leech Building
    Newcastle University Medical School
    Newcastle upon Tyne
    NE2 4HH
Background
Roles
  • MRC Clinician Scientist Fellow, Newcastle University
  • Honorary Consultant in Infectious Diseases, Newcastle upon Tyne Hospitals NHS Foundation Trust 


Previous Positions
  • Wellcome Trust Clinical Research Career Development Fellow, Newcastle University
  • Faculty Fellowship, Institute of Cellular Medicine, Newcastle University
  • NIHR Academic Clinical Lecturership in Infectious Diseases, Newcastle University
  • Specialty Registrar in Infectious Diseases and G(I)M, Northern Deanery
  • Welcome Trust Research Training Fellowship for Clinicians, University of Oxford
  • Phizackerley Senior Scholarship, Balliol College, Oxford
  • Clinical Research Fellowship, University of Oxford
  • Specialty Registrar in Infectious Diseases and G(I)M, West of Scotland Deanery


Qualifications
  • BMed Sci (1st Class Hons.) University of Aberdeen, 2001 (awarded AoPGB&I prize for best intercalated project)
  • MB ChB (Distinction) University of Aberdeen, 2003 (awarded Strachan Bursary prize and Dyce Davidson medal)
  • MRCP (ID) Royal College of Physicians, 2006
  • DPhil University of Oxford, 2014


Fellowships & Memberships of Learned Societies
  • MRC Clinician Scientist Fellowship
  • Wellcome Clinical Research Career Development Fellowship
  • British Infection Association Research Fellowship
  • Welcome Trust Research Training Fellowship for Clinicians


  • Henry Kunkell Society (elected)
  • Nucleic Acid Immunity Society
  • Microbiology Society
  • Association of Physicians of Great Britain & Ireland (AoPGB&I)
  • Royal College of Physicians
  • British Society of Immunology
  • European Society for Immunodeficiencies



Professional Responsibilities
  • Clinical Lead, Infectious Diseases Research Team, Newcastle upon Tyne Hospitals NHS Foundation Trust
  • Director, Infectious Diseases Research Unit, NIHR Newcastle Clinical Research Facility
  • Academic Lead, School of Laboratory Medicine, HEENE
  • Steering group member, AoPGB&I ECR Committee
  • Steering group member, UK Clinical Vaccine Network
  • Data Safety and Monitoring Committee member (4 phase I, 1 phase III clinical vaccine trials)


Editorial and peer review activity
  • Associate Editor, Frontiers in Immunology, Viral Immunology section
  • Peer reviewer for national and international funding bodies (NIHR, Wellcome, MRC, ERC, NZ Health Research Council etc.) and major journals (NEJM, Lancet, Nat Med, J Exp Med, BMJ etc)


Clinical interests

I am a practicing clinician, providing regular clinics in adult infectious diseases, a joint clinic with colleagues in Immunology and regular inpatient ID service. My clinical specialist interests include severe and/or high consequence viral disease, immunodeficiency, and autoinflammatory disease.






Research

Research Interests


Discovery research

Our research aims to define protective and deleterious mechanisms of innate antiviral immunity, in the anticipation that such knowledge may reveal new therapeutic opportunities in viral and inflammatory disease. The processes by which cells detect viral pathogens are reasonably well understood, however less is known about how the downstream response(s) contribute to disease outcome. In this respect, inborn errors of immunity provide a rich resource, teaching us unique lessons about the action and regulation of antiviral signalling in humans.

Type I interferons (IFN-I) are central to the innate response to virus infection. Previously, we have identified human inborn errors which either impair or enhance IFN-I receptor signalling, leading respectively to viral disease or sterile autoinflammation. Thus precise calibration of this response appears essential to host defence and immune homeostasis. 

We are interested in the cellular and molecular regulation of IFN-I signalling and how this contributes to antiviral defence in tissues. We employ cutting-edge techniques of disease modelling, combining CRISPR/Cas9 gene editing in human induced pluripotent stem cell systems with studies in model organisms. We work closely with a range of local, national and international collaborators.

Current projects

Building on a longstanding interest in antiviral responses of macrophages, a current focus is on microglia, the resident macrophages of the brain parenchyma, and the role these cells play in responding to neurotropic viruses and coordinating the brain's IFN signalling network.

Another area of major focus is how innate IFNs intersect in antiviral defence of the airway epithelium. 

Finally, we are interested in modelling sterile IFN-I mediated pathology using in vivo models of human disease entities known as type I interferonopathies. 

Recently, in response to the SARS-CoV-2 pandemic, we embarked on a programme of basic and translational research to characterise immune responses to SARS-CoV-2, contributing to national consortia, including the UK Coronavirus Immunology Consortium (UK-CIC) and the PITCH/SIREN consortium.

Clinical research

In Newcastle upon Tyne Hospitals NHS Foundation Trust, I am clinical lead for the Infectious Diseases research team, delivering a diverse portfolio of phase I-III vaccine and interventional studies as principal investigator. I am UK Chief Investigator on the phase III Moderna ConquerRSV programme and serve on several Data Safety and Monitoring Committees.  




Teaching
Undergraduate

CMB3000 project supervisor

Tutor for BMS suite of programmes


Postgraduate

MRes Immunobiology (MMB8015), Lecturer

MRes Biomedical Research in Health and Disease Module (MMB8018), Lecturer

MSc Physician Associate, Lecturer

MRes project supervisor


I supervise clinical and basic science PhD students and welcome informal enquiries.







Publications

  • Articles

    • Nurmi K, Silventoinen K, Keskitalo S, Rajamaki K, Kouri V-P, Kinnunen M, Jalil S, Maldonado R, Wartiovaara K, Nievas EI, Denita-Juarez SP, Duncan CJA, Kuismin O, Saarela J, Romo I, Martelius T, Parantainen J, Beklen A, Bilicka M, Matikainen S, Nordstrom DC, Kaustio M, Wartiovaara-Kautto U, Kilpivaara O, Klein C, Hauck F, Jahkola T, Hautala T, Varjosalo M, Barreto G, Seppanen MRJ, Eklund KK. Truncating NFKB1 variants cause combined NLRP3 inflammasome activation and type I interferon signaling and predispose to necrotizing fasciitis. Cell Reports Medicine 2024, 5(4), 101503.
    • Milross L, Hunter B, McDonald D, Merces G, Thomson A, Hilkens CMU, Wills J, Rees P, Jiwa K, Cooper N, Majo J, Ashwin H, Duncan CJA, Kaye PM, Bayraktar OA, Filby A, Fisher AJ. Distinct lung cell signatures define the temporal evolution of diffuse alveolar damage in fatal COVID-19. eBioMedicine 2024, 99, 104945.
    • Shaw RH, Greenland M, Stuart ASV, Aley PK, Andrews NJ, Cameron JC, Charlton S, Clutterbuck EA, Collins AM, Darton T, Dinesh T, Duncan CJA, Faust SN, Ferreira DM, Finn A, Goodman AL, Green CA, Hallis B, Heath PT, Hill H, Lambe T, Libri V, Lillie PJ, Morey E, Mujadidi YF, Payne R, Plested EL, Provstgaard-Morys S, Ramasamy MN, Ramsay M, Read RC, Robinson H, Screaton GR, Singh N, Turner DPJ, Turner PJ, White R, Nguyen-Van-Tam JS, Liu X, Snape MD, Com-COV2 Study Group 2. Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study – A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines. Journal of Infection 2023, 86(6), 574-583.
    • Hornsby H, Nicols A, Longet S, Liu C, Tomic A, Angyal A, Kronsteiner B, Tyerman J, Tipton T, Zhang P, Gallis M, Supasa P, Selvaraj M, Abraham P, Neale I, Ali M, Barratt N, Nell J, Gustafsson L, Strickland S, Grouneva I, Rostron T, Moore S, Hering L, Dobson S, Bibi S, Mongkolsapaya J, Lambe T, Wootton D, Hall V, Hopkins S, Dong T, Barnes E, Screaton G, Richter A, Turtle L, Rowland-Jones S, Carroll M, Duncan CJA, Klenerman P, Dunachie S, Payne R, de Silva T. Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history. Nature Communications 2023, 14, 5065.
    • Lee IT, Cosgrove CA, Moore P, Bethune C, Nally R, Bula M, Kalra PA, Clark R, Dargan PI, Boffito M, Sheridan R, Moran E, Darton TC, Burns F, Saralaya D, Duncan CJA, Lillie PJ, SanFrancisco-Ramos A, Galiza EP, Heath PT, Girard B, Parker C, Rust D, Mehta S, deWindt E, Sutherland A, Tomassini JE, Dutko FJ, Chalkias S, Deng W, Chen X, Feng J, Tracy L, Zhou H, Miller JM, Das R, Study Investigators. Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial. Lancet Infectious Disease 2023, Epub ahead of print.
    • Bucciol G, Moens L, Ogishi M, Rinchai D, Matuozzo D, Momenilandi M, Kerrouche N, Cale CM, Treffeisen ER, Al Salamah M, Al-Saud BK, Lachaux A, Duclaux-Loras R, Meignien M, Bousfiha A, Benhsaien I, Shcherbina A, Roppelt A, Gothe F, Houhou-Fidouh N, Hackett SJ, Bartnikas LM, Maciag MC, Alosaimi MF, Chou J, Mohammed RW, Freij BJ, Jouanguy E, Zhang SY, Boisson-Dupuis S, Beziat V, Zhang Q, Duncan CJ, Hambleton S, Casanova JL, Meyts I. Human inherited complete STAT2 deficiency underlies inflammatory viral diseases. Journal of Clinical Investigation 2023, 133(12), e168321.
    • Moore SC, Kronsteiner B, Longet S, Adele S, Deeks AS, Liu C, Dejnirattisai W, Reyes LS, Meardon N, Faustini S, Al-Taei S, Tipton T, Hering LM, Angyal A, Brown R, Nicols AR, Dobson SL, Supasa P, Tuekprakhon A, Cross A, Tyerman JK, Hornsby H, Grouneva I, Plowright M, Zhang P, Newman TAH, Nell JM, Abraham P, Ali M, Malone T, Neale I, Phillips E, Wilson JD, Murray SM, Zewdie M, Shields A, Horner EC, Booth LH, Stafford L, Bibi S, Wootton DG, Mentzer AJ, Conlon CP, Jeffery K, Matthews PC, Pollard AJ, Brown A, Rowland-Jones SL, Mongkolsapaya J, Payne RP, Dold C, Lambe T, Thaventhiran JED, Screaton G, Barnes E, Hopkins S, Hall V, Duncan CJA, Richter A, Carroll M, de Silva TI, Klenerman P, Dunachie S, Turtle L. Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens. Med 2023, 4(3), 191-215.e9.
    • Wilson E, Goswami J, Baqui AH, Doreski PA, Perez-Marc G, Zaman K, Monroy J, Duncan CJA, Ujiie M, Rämet M, Pérez-Breva L, Falsey AR, Walsh EE, Dhar R, Wilson L, Du J, Ghaswalla P, Kapoor A, Lan L, Mehta S, Mithani R, Panozzo CA, Simorellis AK, Kuter BJ, Schödel F, Huang W, Reuter C, Slobod K, Stoszek SK, Shaw CA, Miller JM, Das R, Chen GL. Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults. New England Journal of Medicine 2023, 389(24), 2233-2244.
    • Neale I, Ali M, Kronsteiner B, Longlet S, Abraham P, Deeks AS, Brown A, Moore SC, Stafford L, Dobson SL, Plowright M, Newman TAH, Wu MY, COVIDImmunityPipeline Crick, Carr EJ, Beale R, Otter AD, Hopkins S, Hall V, Tomic A, Payne RP, Barnes E, Richter A, Duncan CJA, Turtle L, deSilva TI, Carroll M, Lambe T, Klenerman P, Dunnachie S, Consortium PITCH. CD4+ and CD8+ T cells and antibodies are associated with protection against Delta vaccine breakthrough infection: A nested case-control study within the PITCH study. mBio 2023, Epub ahead of print.
    • Hanrath AT, Hatton CF, Gothe F, Browne C, Vowles J, Leary P, Cockell SJ, Cowley SA, James WS, Hambleton S, Duncan CJA. Type I Interferon receptor (IFNAR2) deficiency reveals Zika virus cytopathicity in human macrophages and microglia. Frontiers in Immunology 2022, 13, 1035532.
    • Ferrada MA, Savic S, Collins JC, Alessi H, Gutierrez-Rodrigues F, Kumar DBU, Wilson L, Goodspeed W, Topilow JS, Paik JJ, Poulter JA, Kermani TA, Koster MJ, Warrington KJ, Cargo C, Tattersall RS, Duncan CJA, Cantor A, Hoffmann P, Payne EM, Bonnekoh H, Krause K, Cowen EW, Calvo KR, Patel BA, Ombrello AK, Kastner DL, Young NS, Werner A, Grayson PC, Beck DB. Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis. Blood 2022, 140(13), 1496-1506.
    • Milross L, Majo J, Pulle J, Hoggard S, Cooper N, Hunter B, Duncan CJA, Filby A, Fisher AJ. The trajectory of COVID-19 cardiopulmonary disease: insights from an autopsy study of community-based, pre-hospital deaths. ERJ Open Research 2022, 8(4), 00303-2022.
    • Hung RKY, Binns-Roemer E, Booth JW, Hilton R, Fox J, Burns F, Harber M, Ustianowski A, Hamzah L, Burns JE, Clarke A, Price DA, Kegg S, Onyango D, Santana-Suarez B, Campbell L, Bramham K, Sharpe CC, Sabin CA, Winkler CA, Post FA, Booth J, Waters A, Hand J, Clarke C, Murphy S, Murphy M, Campbell M, Richardson C, Knott A, Weir G, Cleig R, Soviarova H, Barbour L, Adams T, Kennard V, Trevitt V, Jones R, Levy J, Schoolmeester A, Duro S, Rabuya M, Jordan D, Solano T, Uzu H, Williams K, Lwanga J, Reid-Amoruso LE, Gamlen H, Stocker RJ, Ryan F, Mahiouz K, Cheetham T, Williams C, Nori A, Thomas C, Venkateshwaran S, Doctor J, Berlanga A, Post F, McQueen L, Bhagwandin P, Barbini B, Wandolo E, Appleby T, Driver L, Parr S, Deng H, Barber J, Crowe A, Taylor C, Poulton M, Boateng V, Klein M-P, O'Brien C, Ohene-Adomako S, Buckingham C, Trotman D, Quinn K, Flanagan K, Sullivan V, Middleditch H, Samuel I, Hamlyn E, McDonald C, Canoso A, Agbasi E, Liskova M, Barber S, Samarawickrama A, Ottaway Z, Norcross C, Oliveira A, Minton J, Lamont G, Cross R, Saiyad G, Ahmed S, Ashworth R, Window N, Murira J, Phyu K, Lindergard G, Shaw J, Holland S, Fox C, Flaherty J, Bevan M-A, George V, Chadwick D, Branch M, Lambert P, Craggs A, Pett S, Lukha H, Vora N, Fiorino M, Nunez MM, Sally D, Pool E, Matthews R, Price DA, Stothard T, Patel B, McVittie I, Kennedy C, Shwab U, Payne B, Duncan S, Dixon J, Schmid M, Evans A, Duncan C, Hunter E, Taha Y, Astill N, Winkler C, David V, Ainsworth J, Vincent R, Saad C, Skinner S, Azzoug H, Russell J, Moussaoui T, Mabonga E, Ward D, Francoise J, Larbi W, Mitchell S, Manning A, Russell V, Ngwu N, Edwards J, Hemat N, Fernandez T, Ferro F, Ferreira J, Nightingale A, Oakes-Monger T, Matila D, Nogueira P, Mutagwanya V, Cosgrove C, Isitt CE, Webb H, Popoola J, Korley K, Mencias M, Ribeiro P, Ramkhelawn R, Lara SO, Sajijad S, Winston A, Shaw A, Petersen C, Ring K, Rosenvinge M, Moyo T, Odong F, Gantert K, Ibe T, Sabin C, Hill T. Sickle Cell Trait and Kidney Disease in People of African Ancestry With HIV. Kidney International Reports 2022, 7(3), 465-473.
    • Willett BJ, Grove J, MacLean OA, et al, PITCH Consortium, The COVID-19 Genomics UK (COG-UK) Consortium, Consortium members from Newcastle University, Duncan C, Payne R, Sanderson R, O'Brien S, Rushton S, Payne B, Waugh S, Taha Y. SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway. Nature Microbiology 2022, 7, 1161-1179.
    • Lazarus R, Taucher C, Brown C, Corbic I, Danon L, Dubischar K, Duncan CJA, Eder-Lingelbach S, Faust SN, Green C, Gokani K, Hochreiter R, Wright JK, Kwon D, Middleditch A, Munro APS, Naker K, Penciu F, Price D, Querton B, Riaz T, Ross-Russell A, Sanchez-Gonzalez A, Wardle H, Warren S, Finn A. Safety and immunogenicity of the inactivated whole-virus adjuvanted vaccine VLA2001: a randomized, dose escalation, double-blind phase 1/2 clinical trial in healthy adults. Journal of Infection 2022, 85(3), 306-317.
    • Shields AM, Anantharachagan A, Arumugakani G, Baker K, Bahal S, Baxendale H, Bermingham W, Bhole M, Boules E, Bright P, Chopra C, Cliffe L, Cleave B, Dempster J, Devlin L, Dhalla F, Diwakar L, Drewe E, Duncan C, Dziadzio M, Elcombe S, Elkhalifa S, Gennery A, Ghanta H, Goddard S, Grigoriadou S, Hackett S, Hayman G, Herriot R, Herwadkar A, Huissoon A, Jain R, Jolles S, Johnston S, Khan S, Laffan J, Lane P, Leeman L, Lowe DM, Mahabir S, Lochlainn DJM, McDermott E, Misbah S, Moghaddas F, Morsi H, Murng S, Noorani S, O'Brien R, Patel S, Price A, Rahman T, Seneviratne S, Shrimpton A, Stroud C, Thomas M, Townsend K, Vaitla P, Verma N, Williams A, Burns SO, Savic S, Richter AG. Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK. Clinical and Experimental Immunology 2022, 209(3), 247-258.
    • Longet S, Hargreaves A, Healy S, Brown R, Hornsby HR, Meardon N, Tipton T, Barnes E, Dunachie S, Duncan CJA, Klenerman P, Richter A, Turtle L, de Silva TI, Carroll MW. mRNA vaccination drives differential mucosal neutralizing antibody profiles in naïve and SARS-CoV-2 previously-infected individuals. Frontiers in Immunology 2022, 13, 953949.
    • Duncan CJA, Skouboe MK, Howarth S, Hollensen AK, Chen R, Borresen ML, Thompson BJ, Spegarova JS, Hatton CF, Staeger FF, Andersen MK, Whittaker J, Paludan SR, Jorgensen SE, Thomsen MK, Mikkelsen JG, Heilmann C, Buhas D, Orbo NF, Bay JT, Marquart HV, De la Morena MT, Klejka JA, Hirschfeld M, Bogwardt L, Forss I, Masmas T, Poulsen A, Noya F, Rouleau G, Hansen T, Zhou S, Abrechtsen A, Alizadehfar R, Allenspach EJ, Hambleton S, Mogensen TH. Life-threatening viral disease in a novel form of autosomal recessive IFNAR2 deficiency in the Arctic. Journal of Experimental Medicine 2022, 219(6), e20212427.
    • Stuart ASV, Shaw RH, Liu X, Greenland M, Aley PK, Andrews NJ, Cameron JC, Charlton S, Clutterbuck EA, Collins AM, Darton T, Dinesh T, Duncan CJA, England A, Faust SN, Ferreira DM, Finn A, Goodman AL, Green CA, Hallis B, Heath PT, Hill H, Horsington BM, Lambe T, Lazarus R, Libri V, Lillie PJ, Mujadidi YF, Payne R, Plested EL, Provstgaard-Morys S, Ramasamy MN, Ramsay M, Read RC, Robinson H, Screaton GR, Singh N, Turner DPJ, Turner PJ, Vichos I, White R, Nguyen-Van-Tam JS, Snape MD. Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial. The Lancet 2022, 399(10319), 36-49.
    • Hung RKY, Rosenberg K-L, David V, Binns-Roemer E, Booth JW, Hilton R, Fox J, Burns F, Ustianowski A, Cosgrove C, Hamzah L, Burns JE, Clarke A, Chadwick D, Price DA, Kegg S, Campbell L, Bramham K, Sabin CA, Post FA, Winkler CA, Waters A, Hand J, Clarke C, Murphy S, Murphy M, Campbell M, Richardson C, Knott A, Weir G, Cleig R, Soviarova H, Barbour L, Adams T, Kennard V, Trevitt V, Jones R, Levy J, Schoolmeester A, Duro S, Rabuya M, Jordan D, Solano T, Uzu H, Williams K, Lwanga J, Reid-Amoruso LE, Gamlen H, Stocker RJ, Ryan F, Mahiouz K, Cheetham T, Williams C, Nori A, Thomas C, Venkateshwaran S, Doctor J, Berlanga A, Santana-Suarez B, McQueen L, Bhagwandin P, Barbini B, Wandolo E, Appleby T, Driver L, Parr S, Deng H, Barber J, Crowe A, Taylor C, Poulton M, Boateng V, Klein M-P, O'Brien C, Ohene-Adomako S, Buckingham C, Trotman D, Quinn K, Flanagan K, Sullivan V, Middleditch H, Samuel I, Hamlyn E, McDonald C, Canoso A, Agbasi E, Liskova M, Barber S, Samarawickrama A, Ottaway Z, Norcross C, Oliveira A, Minton J, Lamont G, Cross R, Saiyad G, Ahmed S, Ashworth R, Window N, Murira J, Phyu K, Lindergard G, Shaw J, Holland S, Fox C, Flaherty J, Bevan M-A, George V, Branch M, Lambert P, Craggs A, Pett S, Lukha H, Vora N, Fiorino M, Nunez MM, Sally D, Pool E, Matthews R, Stothard T, Patel B, McVittie I, Kennedy C, Shwab U, Payne B, Duncan S, Dixon J, Schmid M, Evans A, Duncan C, Hunter E, Taha Y, Astill N, Ainsworth J, Vincent R, Saad C, Skinner S, Azzoug H, Russell J, Moussaoui T, Mabonga E, Ward D, Francoise J, Larbi W, Mitchell S, Manning A, Russell V, Harber M, Ngwu N, Edwards J, Hemat N, Fernandez T, Ferro F, Ferreira J, Nightingale A, Oakes-Monger T, Matila D, Nogueira P, Mutagwanya V, Isitt CE, Webb H, Popoola J, Korley K, Mencias M, Ribeiro P, Ramkhelawn R, Lara SO, Sajijad S, Winston A, Shaw A, Petersen C, Ring K, Rosenvinge M, Moyo T, Odong F, Gantert K, Ibe T, Onyango D, Hill T. GSTM1 Copy Number and Kidney Disease in People With HIV. Kidney International Reports 2022, 7(8), 1901-1904.
    • Hung RKY, Binns-Roemer E, Booth JW, Hilton R, Harber M, Santana-Suarez B, Campbell L, Fox J, Ustianowski A, Cosgrove C, Burns JE, Clarke A, Price DA, Chadwick D, Onyango D, Hamzah L, Bramham K, Sabin CA, Winkler CA, Post FA, Booth J, Waters A, Hand J, Clarke C, Murphy S, Murphy M, Campbell M, Richardson C, Knott A, Weir G, Cleig R, Soviarova H, Barbour L, Adams T, Kennard V, Trevitt V, Jones R, Levy J, Schoolmeester A, Duro S, Rabuya M, Jordan D, Solano T, Uzu H, Williams K, Lwanga J, Reid-Amoruso LE, Gamlen H, Stocker RJ, Ryan F, Mahiouz K, Cheetham T, Williams C, Nori A, Thomas C, Venkateshwaran S, Doctor J, Berlanga A, Post F, McQueen L, Bhagwandin P, Barbini B, Wandolo E, Appleby T, Driver L, Parr S, Deng H, Barber J, Crowe A, Taylor C, Poulton M, Boateng V, Klein M-P, O'Brien C, Ohene-Adomako S, Buckingham C, Trotman D, Quinn K, Flanagan K, Sullivan V, Middleditch H, Samuel I, Hamlyn E, McDonald C, Canoso A, Agbasi E, Liskova M, Barber S, Samarawickrama A, Ottaway Z, Norcross C, Oliveira A, Minton J, Lamont G, Cross R, Saiyad G, Ahmed S, Ashworth R, Window N, Murira J, Phyu K, Lindergard G, Shaw J, Holland S, Fox C, Flaherty J, Bevan M-A, George V, Branch M, Lambert P, Craggs A, Pett S, Lukha H, Vora N, Fiorino M, Nunez MM, Sally D, Pool E, Matthews R, Price DA, Stothard T, Patel B, McVittie I, Kennedy C, Shwab U, Payne B, Duncan S, Dixon J, Schmid M, Evans A, Duncan C, Hunter E, Taha Y, Astill N, Winkler C, David V, Ainsworth J, Vincent R, Kegg S, Saad C, Skinner S, Azzoug H, Russell J, Moussaoui T, Mabonga E, Ward D, Francoise J, Larbi W, Mitchell S, Manning A, Russell V, Burns F, Ngwu N, Edwards J, Hemat N, Fernandez T, Ferro F, Ferreira J, Nightingale A, Oakes-Monger T, Matila D, Nogueira P, Mutagwanya V, Isitt CE, Webb H, Popoola J, Korley K, Mencias M, Ribeiro P, Ramkhelawn R, Lara SO, Sajijad S, Winston A, Shaw A, Petersen C, Ring K, Rosenvinge M, Moyo T, Odong F, Gantert K, Ibe T, Sabin C, Hill T. Genetic Variants of APOL1 Are Major Determinants of Kidney Failure in People of African Ancestry With HIV. Kidney International Reports 2022, 7(4), 786-796.
    • Jackson RM, Hatton CF, Spegarova JS, Georgiou M, J Collin, E Stephenson, B Verdon, IJ Haq, R Hussain, JM Coxhead, H-S Mudhar, B Wagner, M Hasoon, T Davey, P Rooney, A Khan, C Ward, M Brodlie, M Haniffa, S Hambleton, L Armstrong, F Figueiredo, Queen R, Duncan CJ, Lako M. Conjunctival epithelial cells resist productive SARS-CoV-2 infection. Stem Cell Reports 2022, 17(7), 1699-1713.
    • Vlachogiannis N, Baker K, Georgiopoulos G, Lazaridis C, Schim van der Loeff I, Hanrath A, Sopova K, Tual-Chalot S, Gatsiou A, Spyridopoulos I, Stamatelopoulos K, Duncan C, Stellos K. Clinical frailty, and not features of acute infection, is associated with late mortality in COVID-19: a retrospective cohort study. Journal of Cachexia, Sarcopenia and Muscle 2022, 13(3), 1502-1513.
    • Adler H, Gould S, Hine P, Snell LB, Wong W, Houlihan CF, Osborne JC, Rampling T, Beadsworth MBJ, Duncan CJA, Dunning J, Fletcher TE, Hunter ER, Jacobs M, Khoo SH, Newsholme W, Porter D, Porter RJ, Ratcliffe L, Schmid ML, Semple MG, Tunbridge AJ, Wingfield T, Price NM, on behalf of the NHS England High Consequence Infectious Diseases (Airborne) Network. Clinical features and management of human monkeypox: a retrospective observational study in the UK. The Lancet Infectious Diseases 2022, 22(8), 1153-1162.
    • RECOVERY Collaborative Group, Inc. The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Hunter E, De Soyza A, Agbeko R, Baker K, Barr A, Cameron E, Campbell Hewson Q, Duncan C, Emonts M, Fenn A, Francis S, Glover Bengtsson J, Greenhalgh A, Hanrath A, Houghton K, Jerry D, Jones G, Kelly S, Lane N, Macfarlane J, McAlinden P, McCullagh I, McDonald S, Mohammed O, Obukofe R, Parker J, Patience A, Payne B, Price D, Razvi S, Robson S, Sanchez Gonzalez A, Stephenson E, Welton R, West S, Wong E, Yelnoorkar J. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet 2022, 399(10325), 665-676.
    • van der Velden FJS, Van Delft F, Owens S, Llevadias J, McKean M, Pulford L, Taha Y, Williamson G, Campbell-Hewson Q, Hambleton S, Payne RP, Duncan C, Johnston C, Spegarova J, Emonts M. Case report: severe acute pulmonary COVID-19 in a teenager post autologous hematopoietic stem cell transplant. Frontiers in Pediatrics 2022, 10, 809061.
    • Gothe F, Stremenova Spegarova J, Hatton CF, Griffin H, Sargent T, Cowley SA, James W, Roppelt A, Shcherbina A, Hauck F, Reyburn HT, Duncan CJA, Hambleton S. Aberrant inflammatory responses to type I interferon in STAT2 or IRF9 deficiency. Journal of Allergy and Clinical Immunology 2022, 150(4), 955-964.e16.
    • Gothe F, Hatton CF, Truong L, Klimova Z, Kanderova V, Fejtkova M, Grainger A, Bigley V, Perthen J, Mitra D, Janda A, Fronkova E, Maravicikova D, Hambleton S, Duncan CJA. A Novel Case of Homozygous Interferon Alpha/Beta Receptor Alpha Chain (IFNAR1) Deficiency With Hemophagocytic Lymphohistiocytosis. Clinical Infectious Diseases 2022, 74(1), 136-139.
    • Voysey M, Costa Clemens SA, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE, Bibi S, Briner C, Cicconi P, Clutterbuck EA, Collins AM, Cutland CL, Darton TC, Dheda K, Dold C, Duncan CJA, Emary KRW, Ewer KJ, Flaxman A, Fairlie L, Faust SN, Feng S, Ferreira DM, Finn A, Galiza E, Goodman AL, Green CM, Green CA, Greenland M, Hill C, Hill HC, Hirsch I, Izu A, Jenkin D, Joe CCD, Kerridge S, Koen A, Kwatra G, Lazarus R, Libri V, Lillie PJ, Marchevsky NG, Marshall RP, Mendes AVA, Milan EP, Minassian AM, McGregor A, Mujadidi YF, Nana A, Padayachee SD, Phillips DJ, Pittella A, Plested E, Pollock KM, Ramasamy MN, Ritchie AJ, Robinson H, Schwarzbold AV, Smith A, Song R, Snape MD, Sprinz E, Sutherland RK, Thomson EC, Török ME, Toshner M, Turner DPJ, Vekemans J, Villafana TL, White T, Williams CJ, Douglas AD, Hill AVS, Lambe T, Gilbert SC, Pollard AJ, Oxford COVID Vaccine Trial Group THE. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. The Lancet 2021, 397(10277), 881-891.
    • Hanrath AT, Schim van der Loeff I, Lendrem DW, Baker KF, Price DA, McDowall P, McDowall K, Cook S, Towns P, Schwab U, Evans A, Dixon J, Collins J, Burton-Fanning S, Saunders D, Harwood J, Samuel J, Schmid ML, Pareja-Cebrian L, Hunter E, Murphy E, Taha Y, Payne BAI, Duncan CJA. SARS-CoV-2 Testing of 11,884 Healthcare Workers at an Acute NHS Hospital Trust in England: A Retrospective Analysis. Frontiers in Medicine 2021, 8, 636160.
    • Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE, Bibi S, Briner C, Cicconi P, Collins AM, Colin-Jones R, Cutland CL, Darton TC, Dheda K, Duncan CJA, Emary KRW, Ewer KJ, Fairlie L, Faust SN, Feng S, Ferreira DM, Finn A, Goodman AL, Green CM, Green CA, Heath PT, Hill C, Hill H, Hirsch I, Hodgson SHC, Izu A, Jackson S, Jenkin D, Joe CCD, Kerridge S, Koen A, Kwatra G, Lazarus R, Lawrie AM, Lelliott A, Libri V, Lillie PJ, Mallory R, Mendes AVA, Milan EP, Minassian AM, McGregor A, Morrison H, Mujadidi YF, Nana A, O'Reilly PJ, Padayachee SD, Pittella A, Plested E, Pollock KM, Ramasamy MN, Rhead S, Schwarzbold AV, Singh N, Smith A, Song R, Snape MD, Sprinz E, Sutherland RK, Tarrant R, Thomson EC, Török ME, Toshner M, Turner DPJ, Vekemans J, Villafana TL, Watson MEE, Williams CJ, Douglas AD, Hill AVS, Lambe T, Gilbert SC, Pollard AJ, Oxford COVID Vaccine Trial Group THE. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 2021, 397(10269), 99-111.
    • Taha Y, Wardle H, Evans AB, Hunter ER, Marr H, Osborne W, Bashton M, Smith D, Burton-Fanning S, Schmid ML, Duncan CJA. Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy. Annals of Clinical Microbiology and Antimicrobials 2021, 20(1), 85.
    • Baker KF, Hanrath AT, Schim van der Loeff I, Kay LJ, Back J, Duncan CJA. National Early Warning Score 2 (NEWS2) to identify inpatient COVID-19 deterioration: a retrospective analysis. Clinical Medicine 2021, 21(2), 84-89.
    • Freij BJ, Hanrath AT, Chen R, Hambleton S, Duncan CJA. Life-threatening influenza, hemophagocytic lymphohistiocytosis and probable vaccine strain varicella in a novel case of homozygous STAT2 deficiency. Frontiers in Immunology 2021, 11, 624415.
    • Payne RP, Longet S, Austin JA, Skelly DT, Dejnirattisai W, Adele S, Meardon N, Faustini S, Al-Taei S, Moore SC, Tipton T, Hering LM, Angyal A, Brown R, Nicols AR, Gillson N, Dobson SL, Amini A, Supasa P, Cross A, Bridges-Webb A, Reyes LS, Linder A, Sandhar G, Kilby JA, Tyerman JK, Altmann T, Hornsby H, Whitham R, Phillips E, Malone T, Hargreaves A, Shields A, Saei A, Foulkes S, Stafford L, Johnson S, Wootton DG, Conlon CP, Jeffery K, Matthews PC, Frater J, Deeks AS, Pollard AJ, Brown A, Rowland-Jones SL, Mongkolsapaya J, Barnes E, Hopkins S, Hall V, Dold C, Duncan CJA, Richter A, Carroll M, Screaton G, de Silva TI, Turtle L, Klenerman P, Dunachie S, Abuelgasim H, Adland E, Adlou S, Akther HD, Alhussni A, Ali M, Ansari MA, Arancibia-Carcamo CV, Bayley M, Brown H, Chalk J, Chand M, Chawla A, Chinnakannan S, Cutteridge J, de Lara C, Denly L, Diffey B, Dimitriadis S, Drake TM, Donnison T, Dupont M, Eyre D, Fairman A, Gardiner S, Gilbert-Jarmillo J, Goulder P, Hackstein C-P, Hambleton S, Haniffa M, Haworth J, Holmes J, Horner E, Jamsen A, Jones C, Kasanyinga M, Kelly S, Kirk R, Knight ML, Lawrie A, Lee L, Lett L, Lillie K, Lim N, Mehta H, Mentzer AJ, O'Donnell D, Ogbe A, Pace M, Payne BAI, Platt G, Poolan S, Provine N, Ramamurthy N, Robinson N, Romaniuk L, Rongkard P, Sampson OL, Simmons B, Spegarova JS, Stephenson E, Subramaniam K, Thaventhiran J, Thomas S, Travis S, Tucker S, Turton H, Watson A, Watson L, Weeks E, Wilson R, Wood S, Wright R, Xiao H, Zawia AAT. Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine. Cell 2021, 184(23), 5699-5714.e11.
    • Stamatelopoulos K, Georgiopoulos G, Baker KF, Tiseo G, Delialis D, Lazaridis C, Barbieri G, Masi S, Vlachogiannis NI, Sopova K, Mengozzi A, Ghiadoni L, Ajdini B, Ghiadoni L, van der Loeff IS, Vlachopoulos C, Dimopoulos MA, Falcone M, Stellos K, Duncan CJA, Tiseo G, Barbieri G, Masi S, Mengozzi A, Falcone M, Monzani F, Menichetti F, Virdis A, Forfori F, Rubia B, Pietro B, Francesco C, Alessandra DR, Giulia B, Fabio G, Paolo M, Marco M, Chiara P, Naria P, Alessandro C, Carrozzi L, Francesco C, Santini M, Alessandro C, Martina B, Matteo B, Elia N, Stefano S, Francesca R, Giovanna F, Maria S, De Marco S, Rachele A, Valeria C, Simone P, Luciano C, Chiara S, Valentina G, Uliana M, Baker KF, van der Loeff IS, Hanrath AT, Hanrath AT, Duncan CJA, Tee SA, Capstick R, Marchitelli G, Li A, Barr A, Eid A, Ahmed S, Bajwa D, Mohammed O. Estimated pulse wave velocity improves risk stratification for all-cause mortality in patients with COVID-19. Scientific Reports 2021, 11(1), 20239.
    • Emary KRW, Golubchik T, Aley PK, Ariani CV, Angus B, Bibi S, Blane B, Bonsall D, Cicconi P, Charlton S, Clutterbuck EA, Collins AM, Cox T, Darton TC, Dold C, Douglas AD, Duncan CJA, Ewer KJ, Flaxman AL, Faust SN, Ferreira DM, Feng S, Finn A, Folegatti PM, Fuskova M, Galiza E, Goodman AL, Green CM, Green CA, Greenland M, Hallis B, Heath PT, Hay J, Hill HC, Jenkin D, Kerridge S, Lazarus R, Libri V, Lillie PJ, Ludden C, Marchevsky NG, Minassian AM, McGregor AC, Mujadidi YF, Phillips DJ, Plested E, Pollock KM, Robinson H, Smith A, Song R, Snape MD, Sutherland RK, Thomson EC, Toshner M, Turner DPJ, Vekemans J, Villafana TL, Williams CJ, Hill AVS, Lambe T, Gilbert SC, Voysey M, Ramasamy MN, Pollard AJ. Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial. The Lancet 2021, 397(10282), 1351-1362.
    • Hatton CF, Botting RA, Duenas ME, Haq IJ, Verdon B, Thompson BJ, Spegarova JS, Gothe F, Stephenson E, Gardner AI, Murphy S, Scott J, Garnett JP, Carrie S, Powell J, Khan CMA, Huang L, Hussain R, Coxhead J, Davey T, Simpson AJ, Haniffa M, Hambleton S, Brodlie M, Ward C, Trost M, Reynolds G, Duncan CJA. Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2. Nature Communications 2021, 12(1), 7092.
    • Baker KF, Hanrath AT, Schim van der Loeff I, Tee SA, Capstick R, Marchitelli G, Li A, Barr A, Eid A, Ahmed S, Bajwa D, Mohammed O, Alderson N, Lendrem C, Lendrem DW, COVID Control Group THE, COVID Clinical Group THE, Pareja-Cebrian L, Welch A, Field J, Payne BAI, Taha Y, Price DA, Gibbins C, Schmid ML, Hunter E, Duncan CJA. COVID-19 Management in a UK NHS Foundation Trust with a High Consequence Infectious Diseases Centre: A Retrospective Analysis. Medical Sciences 2021, 9(1), 6.
    • Manson JJ, Crooks C, Naja M, Ledlie A, Goulden B, Liddle T, Khan E, Mehta P, Martin-Gutierrez L, Waddington KE, Robinson GA, Ribeiro Santos L, McLoughlin E, Snell A, Adeney C, Schim van der Loeff I, Baker KF, Duncan CJA, Hanrath AT, Lendrem BC, De Soyza A, Peng J, J'Bari H, Greenwood M, Hawkins E, Peckham H, Marks M, Rampling T, Luintel A, Williams B, Brown M, Singer M, West J, Jury EC, Collin M, Tattersall RS. COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study. The Lancet Rheumatology 2020, 2(10), e594-e602.
    • Holden B, Quinney A, Padfield S, Morton W, Coles S, Manley P, Wensley A, Hutchinson C, Lillie PJ, Duncan CJA, Schmid ML, Li A, Foster K, Anaraki S, Dabrera G, Zambon M, Hughes GJ, Gent M. COVID-19: Public Health management of the first two confirmed cases identified in the UK. Epidemiology and Infection 2020, 148, e194.
    • Sayer JA, Mabillard H, Tedd H, Speight A, Duncan C, Price DA. Case Report: Renal potassium wasting in SARS-CoV-2 infection. F1000Research 2020, 9, 659.
    • Duncan CJA, Thompson BJ, Chen R, Rice GI, Gothe F, Young DF, Lovell SC, Shuttleworth VG, Brocklebank V, Corner B, Skelton AJ, Bondet V, Coxhead J, Duffy D, Fourrage C, Livingston JH, Pavaine J, Cheesman E, Bitetti S, Grainger A, Acres M, Innes BA, Mikulasova A, Sun R, Hussain H, Wright R, Wynn R, Zarhrate M, Zeef LAH, Wood K, Hughes SM, Harris CL, Engelhardt KE, Crow YJ, Randall RE, Kavanagh D, Hambleton S, Briggs TA. Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT2. Science Immunology 2019, 4(42), eaav7501.
    • Duncan CJA, Charlton F, Bower M, Price DA. The unholy trinity of human herpesvirus 8-associated malignancy in a person living with HIV-1. AIDS 2018, 32(3), 404–406.
    • Widdrington JD, Emmerson I, Cullinan M, Narayanan M, Klejnow E, Watson A, Ong ELC, Schmid ML, Price DA, Schwab U, Duncan CJA. Pyogenic Spondylodiscitis: Risk Factors for Adverse Clinical Outcome in Routine Clinical Practice. Medical Sciences 2018, 6(4), 96.
    • Duncan CJA, Dinnigan E, Theobald R, Grainger A, Skelton AJ, Hussain R, Willet JDP, Swan DJ, Coxhead J, Thomas MF, Thomas J, Zamvar V, Slatter MA, Cant AJ, Engelhardt KR, Hambleton S. Early-onset autoimmune disease due to a heterozygous loss-of-function mutation in TNFAIP3 (A20). Annals of the Rheumatic Diseases 2018, 77(5), 783-786.
    • Ryan L, Heed A, Foster J, Valappil M, Schmid ML, Duncan CJA. Acute kidney injury (AKI) associated with intravenous aciclovir in adults: incidence and risk factors in clinical practice. International Journal of Infectious Disease 2018, 74, 97-99.
    • Bliss CM, Drammeh A, Bowyer G, Sanou GS, Jagne YJ, Ouedraogo O, Edwards NJ, Tarama C, Ouedraogo N, Ouedraogo M, NjieJobe J, Diarra A, Afolabi MO, Tiono AB, Yaro JB, Adetifa UJ, Hodgson SH, Anagnostou NA, Roberts R, Duncan CJ, Cortese R, Viebig NK, Leroy O, Lawrie AM, Flanagan KL, Kampmann B, Imoukhuede EB, Sirima SB, Bojang K, Hill AV, Nebie I, Ewer KJ. Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants. Molecular Therapy 2017, 25(2), 547-559.
    • Afolabi MO, Tiono AB, Adetifa UJ, Yaro JB, Drammeh A, Nebie I, Bliss C, Hodgson SH, Anagnostou NA, Sanou GS, Jagne YJ, Ouedraogo O, Tamara C, Ouedraogo N, Ouedraogo M, Njie-Jobe J, Diarra A, Duncan CJ, Cortese R, Nicosia A, Roberts R, Viebig NK, Leroy O, Lawrie AM, Flanagan KL, Kampman B, Bejon P, Imoukhuede EB, Ewer KJ, Hill AV, Bojang K, Sirima S. Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants. Molecular Therapy 2016, 24(8), 1470–1477.
    • Duncan CJA, Mohamad SMB, Young DF, Skelton AJ, Leahy TR, Munday DC, Butler KM, Morfopoulou S, Brown JR, Hubank M, Connell J, Gavin PJ, McMahon C, Dempsey E, Lynch NE, Jacques TS, Valappil M, Cant AJ, Breuer J, Engelhardt KR, Randall RE, Hambleton S. Human IFNAR2 deficiency: lessons for antiviral immunity. Science Translational Medicine 2015, 7(307), 307ra154.
    • Kimani D, Jagne YJ, Cox M, Kimani E, Bliss CM, Gitau E, Ogwang C, Afolabi MO, Bowyer G, Collins KA, Edwards N, Hodgson SH, Duncan CJ, Spencer AJ, Knight MG, Drammeh A, Anagnostou NA, Berrie E, Moyle S, Gilbert SC, Soipei P, Okebe J, Colloca S, Cortese R, Viebig NK, Roberts R, Lawrie AM, Nicosia A, Imoukhuede EB, Bejon P, Chilengi R, Bojang K, Flanagan KL, Hill AV, Urban BC, Ewer KJ. Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations. Molecular Therapy 2014, 22(11), 1992-2003.
    • Baxter AE, Russell RA, Duncan CJ, Moore MD, Willberg CB, Pablos JL, Finzi A, Kaufmann DE, Ochsenbauer C, Kappes JC, Groot F, Sattentau QJ. Macrophage Infection via Selective Capture of HIV-1-Infected CD4+ T Cells. Cell Host and Microbe 2014, 16(6), 711-721.
    • Duncan CJ, Williams JP, Schiffner T, Gartner K, Ochsenbauer C, Kappes J, Russell RA, Frater J, Sattentau QJ. High-multiplicity HIV-1 infection and neutralizing antibody evasion mediated by the macrophage-T cell virological synapse. Journal of Virology 2014, 88(4), 2025-2034.
    • Biswas S, Choudhary P, Elias SC, Miura K, Milne KH, deCassan SC, Collins KA, Halstead FD, Bliss CM, Ewer KJ, Osier FH, Hodgson SH, Duncan CJ, O'Hara GA, Long CA, Hill AV, Draper SJ. Assessment of humoral immune responses to blood-stage malaria antigens following ChAd63-MVA immunization, controlled human malaria infection and natural exposure. PLoS One 2014, 9(9), e107903.
    • Walker KM, Okitsu S, Porter DW, Duncan C, Amacker M, Pluschke G, Cavanagh DR, Hill AV, Todryk SM. Antibody and T-cell responses associated with experimental human malaria infection or vaccination show limited relationships. Immunology 2014, 145(1), 71-81.
    • Elias SC, Choudhary P, deCassan SC, Biswas S, Collins KA, Halstead FD, Bliss CM, Ewer KJ, Hodgson SH, Duncan CJ, Hill AV, Draper SJ. Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infection. Immunology 2014, 141(4), 628-644.

  • Conference Proceedings (inc. Abstract)

    • Duncan C, Mohamad S, Young D, Skelton A, Leahy R, Munday D, Butler K, Morfopoulou S, Brown J, Hubank M, Connell J, Gavin P, McMahon C, Dempsey E, Lynch N, Jacques T, Valappil M, Cant A, Engelhardt K, Breuer J, Randall R, Hambleton S. Human IFNAR2 Deficiency: Lessons For Antiviral Immunity. In: UKPIN 2015 Meeting. 2015, Belfast, Northern Ireland: Wiley-Blackwell Publishing Ltd.

  • Letters

  • Note

    • Willett BJ, Grove J, MacLean OA, Wilkie C, De Lorenzo G, Furnon W, Cantoni D, Scott S, Logan N, Ashraf S, Manali M, Szemiel A, Cowton V, Vink E, Harvey WT, Davis C, Asamaphan P, Tong L, Orton R, Hughes J, Holland P, Silva V, Puxty K, da Silva Filipe A, Shaaban S, Holden MTG, Pinto RM, Gunson R, Templeton K, Murcia PR, Patel AH, Klenerman P, Dunachie S, Dunachie S, Klenerman P, Barnes E, Brown A, Adele S, Kronsteiner B, Murray SM, Abraham P, Deeks A, Ansari MA, de Silva T, Turtle L, Moore S, Austin J, Richter A, Duncan C, Payne R, Ash A, Koshy C, Kele B, Cutino-Moguel T, Fairley DJ, McKenna JP, Curran T, Adams H, Fraser C, Bonsall D, Fryer H, Lythgoe K, Thomson L, Golubchik T, Murray A, Singleton D, Beckwith SM, Mantzouratou A, Barrow M, Buchan SL, Reynolds N, Warne B, Maksimovic J, Spellman K, McCluggage K, John M, Beer R, Afifi S, Morgan S, Mack A, Marchbank A, Price A, Morriss A, Bresner C, Kitchen C, Merrick I, Southgate J, Guest M, Jones O, Munn R, Connor TR, Whalley T, Workman T, Fuller W, Patel A, Patel B, Nebbia G, Edgeworth J, Snell LB, Batra R, Charalampous T, Beckett AH, Shelest E, Robson SC, Underwood AP, Taylor BEW, Yeats CA, Aanensen DM, Abudahab K, Menegazzo M, Joseph A, Clark G, Howson-Wells HC, Berry L, Khakh M, Lister MM, Boswell T, Fleming VM, Holmes CW, McMurray CL, Shaw J, Tang JW, Fallon K, Odedra M, Willford NJ, Bird PW, Helmer T, Williams L-A, Sheriff N, Campbell S, Raviprakash V, Blakey V, Moore C, Sang F, Debebe J, Carlile M, Loose MW, Holmes N, Wright V, Torok ME, Hamilton WL, Carabelli AM, Jermy A, Blane B, Churcher CM, Ludden C, Aggarwal D, Westwick E, Brooks E, McManus GM, Galai K, Smith K, Smith KS, Cox MG, Fragakis M, Maxwell P, Judges S, Peacock SJ, Feltwell T, Kenyon A, Eldirdiri S, Davis T, Taylor JF, Tan NK, Zarebski AE, Gutierrez B, Raghwani J, du Plessis L, Kraemer MUG, Pybus OG, Francois S, Attwood SW, Vasylyeva TI, Jahun AS, Goodfellow IG, Georgana I, Pinckert ML, Hosmillo M, Izuagbe R, Chaudhry Y, Ryan F, Lowe H, Moses S, Bedford L, Cargill JS, Hughes W, Moore J, Stonehouse S, Shah D, Lee JCD, Brown JR, Harris KA, Atkinson L, Storey N, Spyer MJ, Flaviani F, Alcolea-Medina A, Sehmi J, Ramble J, Ohemeng-Kumi N, Smith P, Bertolusso B, Thomas C, Vernet G, Lynch J, Moore N, Cortes N, Williams R, Kidd SP, Levett LJ, Pusok M, Grant PR, Kirk S, Chatterton W, Xu-McCrae L, Smith DL, Young GR, Bashton M, Kitchman K, Gajee K, Eastick K, Lillie PJ, Burns PJ, Everson W, Cox A, Holmes AH, Bolt F, Price JR, Pond M, Randell PA, Madona P, Mookerjee S, Volz EM, Geidelberg L, Ragonnet-Cronin M, Boyd O, Johnson R, Pope CF, Witney AA, Monahan IM, Laing KG, Smollett KL, Smollett KL, McNally A, McMurray C, Stockton J, Quick J, Loman NJ, Poplawski R, Nicholls S, Rowe W, Castigador A, Macnaughton E, Bouzidi KE, Sudhanva M, Lampejo T, Martinez Nunez RT, Breen C, Sluga G, Withell KT, Machin NW, George RP, Ahmad SSY, Pritchard DT, Binns D, Wong N, James V, Williams C, Illingworth CJ, Jackson C, de Angelis D, Pascall D, Pascall D, Mukaddas A, Broos A, da Silva Filipe A, Mair D, Robertson DL, Wright DW, Thomson EC, Starinskij I, Tsatsani I, Shepherd JG, Nichols J, Hughes J, Nomikou K, Tong L, Orton RJ, Vattipally S, Harvey WT, Sanderson R, O'Brien S, Rushton S, Perkins J, Blacow R, Gunson RN, Gallagher A, Wastnedge E, Templeton KE, McHugh MP, Dewar R, Cotton S, Coupland L, Stanley R, Dervisevic S, Spurgin LG, Smith L, Graham C, Padgett D, Barton E, Scott G, Cross A, Mirfenderesky M, Swindells E, Greenaway J, Denton-Smith R, Turnbull R, Idle G, Cole K, Hollis A, Nelson A, McCann CM, Henderson JH, Crown MR, Yew WC, Stanley W, Duckworth N, Clarke P, Walsh S, Sloan TJ, Bicknell K, Impey R, Wyllie S, Elliott S, Glaysher S, Bradley DT, Killough NF, Wyatt T, Bosworth A, Vipond BB, Pearson C, Allara E, Robinson E, Pymont HM, Osman H, Muir P, Hopes R, Hutchings S, Curran MD, Parmar S, Thornton A, Lackenby A, Bishop C, Bibby D, Lee D, Gallagher E, Dabrera G, Harrison I, Hubb J, Twohig KA, Chand M, Ellaby N, Manesis N, Myers R, Platt S, Mbisa T, Chalker V, Yebra G, Yebra G, Holden MTG, Shaaban S, Rooke S, Birchley A, Adams A, Davies A, Gaskin A, Gatica-Wilcox B, McKerr C, Moore C, Williams C, Williams C, Heyburn D, De Lacy E, Hilvers E, Downing F, Pugh G, Jones H, Asad H, Coombes J, Hey J, Powell J, Watkins J, Evans JM, Fina L, Gifford L, Gilbert L, Graham L, Perry M, Morgan M, Bull M, Pacchiarini N, Craine N, Corden S, Kumziene-Summerhayes S, Rey S, Taylor S, Cottrell S, Jones S, Edwards S, Annett T, Trotter AJ, Mather AE, Aydin A, Page AJ, Baker DJ, Foster-Nyarko E, Kay GL, O'Grady J, de Oliveira Martins L, Meadows L, Alikhan N-F, Prosolek SJ, Rudder S, Le-Viet T, Casey A, Ratcliffe L, Singh A, Mariappan A, Baxter C, Radulescu C, Simpson DA, Lavin D, Rogan F, Miskelly J, Fuchs M, Tang M, Carvalho SF, Bridgett S, Skvortsov T, Molnar Z, Ramadan NA, Knight BA, Jones CR, Auckland C, Morcrette H, Poyner J, Irish-Tavares D, Witele E, Hart J, Mahungu TW, Haque T, Bourgeois Y, Fearn C, Cook KF, Loveson KF, Goudarzi S, Evans C, Partridge DG, Johnson K, Yavus M, Raza M, Mower C, Baker P, Essex S, Bonner S, Murray LJ, Watson LK, Liggett S, Lawton AI, Lyons RA, Payne BAI, Eltringham G, Collins J, Waugh S, Burton-Fanning S, Taha Y, Jeanes C, Gomes AN, Murray DR, Kimuli M, Dobie D, Ashfield P, Best A, Percival B, Moles-Garcia E, Ashford F, Mirza J, Crawford L, Mayhew M, Cumley N, Megram O, Frampton D, Heaney J, Byott M, Houlihan C, Williams CA, Nastouli E, Lowe HL, Hartley JA, Breuer J, Maftei L, Ensell L, Cotic M, Mondani M, Driscoll M, Bayzid N, Williams RJ, Roy S, Mahanama AIK, Samaraweera B, Wilson-Davies E, Pelosi E, Umpleby H, Wheeler H, Prieto JA, Saeed K, Harvey M, Jeremiah S, Silviera S, Aplin S, Sass T, Macklin B, Crudgington D, Sheridan LA, Cogger BJ, Malone CS, Munemo F, Huckson H, Lewis J, Easton LJ, Mutingwende M, Erkiert MJ, Hassan-Ibrahim MO, Chaloner NJ, Podplomyk O, Randell P, Nicodemi R, Lowdon S, Somassa T, Richter A, Beggs A, Hesketh AR, Smith CP, Bucca G, Ruis C, Cormie C, Higginson EE, Young J, Dias J, Kermack LM, Maes M, Gupta RK, Forrest S, Girgis ST, Davidson RK, O'Toole A, Rambaut A, Jackson B, Balcazar CE, Maloney D, Scher E, McCrone JT, Williamson KA, Gallagher MD, Medd N, Colquhoun R, Stanton TD, Williams T, Hill V, Jeffries AR, Temperton B, Sambles CM, Studholme DJ, Warwick-Dugdale J, Jackson LM, Michelsen ML, Manley R, Michell SL, Darby AC, Lucaci AO, Nelson C, Wierzbicki C, Vamos EE, Webster HJ, Jackson KA, Rainbow L, Hughes M, Whitehead M, Gemmell M, Iturriza-Gomara M, Eccles R, Gregory R, Haldenby ST, Paterson S, Angyal A, Keeley AJ, Foulkes BH, Lindsey BB, Wang D, Hornsby HR, Green LR, Pohare M, Gallis M, Parker MD, Whiteley M, Smith N, Wolverson P, Zhang P, Hansford SE, Hsu SN, Louka SF, de Silva TI, Freeman TM, Mori M, Park EJ, Hill JD, Dey J, Ball J, Chappell JG, McClure PC, Byaruhanga T, Fanaie A, Yaze G, Hilson RA, Trebes A, Green A, Buck D, MacIntyre-Cockett G, Todd JA, Bassett AR, Whitwham A, Langford CF, Rajan D, Kwiatkowski D, Harrison EM, Bronner IF, Tovar-Corona JM, Liddle J, Durham J, Bellis KL, Lewis K, Aigrain L, Redshaw NM, Davies RM, Moll RJ, McCarthy SA, Lensing SV, Leonard S, Farr BW, Scott C, Beaver C, Ariani CV, Weldon D, Jackson DK, Betteridge E, Tonkin-Hill G, Johnston I, Martincorena I, Bonfield J, Barrett JC, Sillitoe J, Keatley J-P, Oliver K, James K, Shirley L, Prestwood L, Foulser L, Gourtovaia M, Dorman MJ, Quail MA, Spencer Chapman MH, Park NR, Livett R, Amato R, Kay S, Goodwin S, Thurston SAJ, Rajatileka S, Goncalves S, Lo S, Sanderson T, Maclean A, Goldstein EJ, Ferguson L, Tomb R, Catalan J, Jones N, Haughney J, Robertson DL, Palmarini M, Ray S, Thomson EC. Publisher Correction: SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway (Nature Microbiology, (2022), 7, 8, (1161-1179), 10.1038/s41564-022-01143-7). Nature Microbiology 2022, 7(10), 1709.

  • Reviews